Prozumab

N/A

Report date: 2024/11/26 11:21:47

Base Information

Drug NameProzumab
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Heat shock 70 kDa protein 14
TargetsHeat shock 70 kDa protein 14
Therapy Area/IndicationsInflammatory Bowel DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHadassah University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesHadassah University Hospital
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A